February 27, 2019
Teva Pharmaceuticals' closely watched challenge to the U.S. Food and Drug Administration's new policy on generic-drug exclusivity is premature because the company may have forfeited exclusivity under other policies, a D.C. federal judge ruled Tuesday.
November 05, 2018
Teva Pharmaceuticals' high-profile challenge to a new U.S. Food and Drug Administration policy on generic-drug exclusivity is wildly speculative and has virtually no chance of succeeding, the FDA told a D.C. federal judge Friday.
October 18, 2018
A new U.S. Food and Drug Administration policy threatens to deprive generic-drug makers of lucrative exclusivity even when they expose themselves to litigation by challenging patents for brand-name drugs, Teva Pharmaceuticals said in a lawsuit filed Wednesday.